AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 129 filers reported holding AFFIMED N V in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,035 | -72.4% | 129,807 | -65.5% | 0.00% | – |
| Q2 2023 | $224,811 | +814.7% | 375,812 | +1796.0% | 0.00% | – |
| Q4 2022 | $24,578 | -86.3% | 19,821 | -77.3% | 0.00% | – |
| Q3 2022 | $179,000 | -9.1% | 87,188 | +22.4% | 0.00% | – |
| Q2 2022 | $197,000 | -8.4% | 71,203 | +44.4% | 0.00% | – |
| Q1 2022 | $215,000 | -84.3% | 49,300 | -80.1% | 0.00% | – |
| Q4 2021 | $1,371,000 | +30.8% | 248,318 | +46.4% | 0.00% | – |
| Q3 2021 | $1,048,000 | -26.8% | 169,600 | +0.6% | 0.00% | – |
| Q2 2021 | $1,432,000 | +322.4% | 168,525 | +293.6% | 0.00% | – |
| Q1 2021 | $339,000 | +78.4% | 42,819 | +31.1% | 0.00% | – |
| Q4 2020 | $190,000 | +183.6% | 32,658 | -23.3% | 0.00% | – |
| Q1 2020 | $67,000 | -85.6% | 42,583 | -73.7% | 0.00% | -100.0% |
| Q2 2019 | $465,000 | +545.8% | 162,114 | +842.0% | 0.00% | – |
| Q1 2019 | $72,000 | +118.2% | 17,209 | +28.0% | 0.00% | – |
| Q2 2016 | $33,000 | -73.0% | 13,442 | -30.6% | 0.00% | -100.0% |
| Q3 2014 | $122,000 | – | 19,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |